tert-butyl 4-(2-ethoxy-2-oxoethyl)-4-fluoropiperidine-1-carboxylate, 95.0%, 1g

1,5-Diphénylcarbazide, min 97 %, pa, ACS, 10 g, emballage plastique.

2-Methyl-5-(trifluoromethyl)benzonitrile, 95.0%, 5g

6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-2-amine dihydrochloride, 95.0%, 25g

Ethyl (1S,5R,6S)-5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate, 95.0%, 10g

Cyclohexanebutyrate de nickel, AAS 2,5 g

6-Benzyloxypyridin-3-amine, 95+%, 250mg

1,3-dimethyl-1,3-dihydro-2H-benzimidazol-2-one, 95.0%, 5g

METHYL 3-(BROMOMETHYL)-4-NITROBENZOATE, 95.0%, 250mg

Cyclohexanone tosylhydrazone, 98%, 250mg

(3R)-3-(propan-2-yl)pyrrolidine hydrochloride, 95.0%, 5g

(2-Nitro-4-trifluoromethyl-phenyl)-hydrazine, 95.0%, 1g

1-(3-Bromo-4-methoxyphenyl)-2,2,2-trifluoroethan-1-ol, 95%, 500mg